AAPM has contracted with NCRP to provide each AAPM Member in good standing access and download privileges of electronically available NCRP reports, commentaries and statements. This report was prepared by the National Council on Radiation Protection and Measurements (NCRP). The Council strives to provide accurate, complete and useful information in its reports. However, neither the NCRP, the members of NCRP, other persons contributing to or assisting in the preparation of this report, nor any person acting on the behalf of any of these parties (a) makes any warranty or representation, express or implied, with respect to the accuracy, completeness or usefulness of the information contained in this report, or that the use of any information, method or process disclosed in this report may not infringe on privately owned rights; or (b) assumes any liability with respect to the use of, or for damages resulting from the use of, any information, method or process disclosed in this report.
 |
Report No. 055 - Protection of the Thyroid Gland in the Event of Releases of Radioiodine (1977)  Price: $25 PDF (AAPM Members FREE) Category: Reports This Report considers the feasibility of utilizing thyroid blocking agents, as an additional option, for protection of the public in case of off-site releases. NCRP does not take any position concerning the question of utilizing thyroid blocking agents in any given situation. Rather, the purpose of this Report is to define the efficacy of such agents and the contraindications for their use, and, hence, the potential for use of thyroid blocking agents. In view of concern about the possibility of large releases of radioiodine from nuclear reactors, the use of evacuation to mitigate the consequences of such a relew ia also discussed in this Report. Scientific Committee: Eugene L. Saenger, Chairman Eight expert members. |
DISCLAIMER